Top compounds associated with response to RSAD2


Feature Type Standardized
Nominal ANOVA
mRNA LY317615 GDSC1000 pan-cancer AAC 0.11 0.0009
mRNA PD-0332991 CCLE pan-cancer AAC -0.15 0.001
mRNA WH-4-023 GDSC1000 pan-cancer AAC 0.15 0.002
mRNA paclitaxel CCLE pan-cancer AAC -0.14 0.002
mRNA AP-24534 GDSC1000 pan-cancer AAC 0.099 0.003
mRNA Vandetanib CCLE pan-cancer AAC 0.14 0.003
mRNA Panobinostat CCLE pan-cancer AAC -0.12 0.003
mRNA Docetaxel gCSI pan-cancer AAC -0.16 0.004
mRNA paclitaxel gCSI pan-cancer AAC -0.15 0.004
mRNA 17-AAG CCLE pan-cancer AAC -0.13 0.004
Download CSV